Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Uiterwaal, C. S. P. M.
space
  arrow  Hofman, A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Postprandial Triglyceride Response in Young Adult Men and Familial Risk for Coronary Atherosclerosis

right arrow Cuno S. P. M. Uiterwaal; Diederick E. Grobbee; Jacqueline C. M. Witteman; Willy-Anne H. J. van Stiphout; Xeno H. Krauss; Louis M. Havekes; Anthony M. de Bruijn; Arie van Tol; and Albert Hofman

15 October 1994 | Volume 121 Issue 8 | Pages 576-583

Objective: To determine whether an increased familial risk for coronary artery disease in young adult men is related to changes in postprandial lipoprotein metabolism.

Design: Cross-sectional study.

Setting: Coronary angiography departments of four central general hospitals in the Netherlands.

Patients: 80 sons (mean age, 24.8 years) of men with severe coronary artery disease and 55 sons (mean age, 23.2 years) of controls.

Measurements: Postprandial levels of serum triglycerides, retinyl palmitate, and total cholesterol were measured during a 12-hour period after a standardized oral lipid load.

Results: Both groups showed a marked increase in levels of serum triglyceride and retinyl palmitate after lipid loading, reaching a maximum 4 to 6 hours postprandially. No changes in postprandial total cholesterol levels were observed in either group. Sons of men with coronary artery disease had prolonged postprandial hypertriglyceridemia when compared with sons of controls. Significant differences in postprandial triglyceride levels were found at 8 hours (difference, 0.35 mmol/L; 95% CI, 0.07 to 0.62 mmol/L), at 10 hours (difference, 0.21 mmol/L; CI, 0.06 to 0.36 mmol/L), and at 12 hours after lipid loading (difference, 0.13 mmol/L; CI, 0.01 to 0.26 mmol/L). Levels of postprandial retinyl palmitate were also slightly, but not statistically, different (mainly after 6 hours).

Conclusions: Healthy young adult sons, whose fathers have established coronary artery disease, have prolonged postprandial hypertriglyceridemia. Changes in postprandial lipoprotein metabolism appear to be associated with familial risk for coronary atherosclerosis.


Atherosclerosis starts early in life [1, 2]. Postprandial lipoprotein metabolism is proposed to be involved in this process [3]. Cholesteryl ester-rich remnants of triglyceride-rich lipoproteins may directly promote accumulation of cholesteryl esters in the arterial wall [4-6]. Further, it has been reported [7, 8] that the protective effect of increased levels of high-density lipoprotein (HDL) cholesterol on the risk for coronary artery disease may not only be explained by their role in reverse cholesterol transport but also by the relation between HDL and triglyceride metabolism [9]. Plasma triglycerides have an effect on HDL composition and HDL cholesterol levels [10]; an inverse relation between HDL2 levels and postprandial triglyceride levels has been shown [11]. Levels and composition of HDL could thus be a reflection of the effectiveness of triglyceride-rich lipoprotein catabolism. A deranged metabolism of triglyceride-rich lipoproteins in plasma has been reported in familial dysbetalipoproteinemia [12, 13], a disease associated with premature coronary atherosclerosis.

Studies comparing patients with coronary artery disease and persons without the disease have shown that differences with respect to postprandial hypertriglyceridemia [14-16] and postprandial retinyl palmitate concentrations (a marker of chylomicrons and their remnants) are detectable after an oral lipid load [14, 15]. These results suggest a delayed clearance of these lipoproteins in patients with coronary artery disease. Thus, accumulating evidence indicates that postprandial lipemia plays an important role in causing coronary artery disease, and the implications with respect to treatment and primary prevention are increasingly being recognized [17].

Postprandial lipoprotein metabolism has not yet been studied in children and young adults with an increased risk for coronary atherosclerosis. In our study, male offspring of men with clinical manifestations of and angiographically proven coronary atherosclerosis were compared with male offspring of men who did not have coronary atherosclerosis (negative result after angiography). This approach enabled us to study a group of healthy young adults at high familial risk for developing clinical manifestations of coronary artery disease later in life.

We assessed whether changes in the triglyceride response to a standardized oral lipid load, as reported in patients with coronary artery disease, can also be measured in healthy young male offspring of such patients.


Methods
space
up arrowTop
dotMethods
down arrowResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

Participants

Men with very severe coronary artery disease (patients), defined as more than 70% occlusion in at least three major coronary vessels, were selected from coronary angiography databases of cardiology departments of the Zuiderziekenhuis Rotterdam (1988 to 1991), the University Hospital Rotterdam (1988 to 1989), the Refaja Ziekenhuis in Dordrecht (1990 to 1991), and the Antonius Ziekenhuis in Nieuwegein (1992), all hospitals situated in the Netherlands. Simultaneously, a reference group of men [controls] was selected who at coronary angiography had no or, at most, only minor lesions, defined as 20% stenosis or less in all coronary vessels. Further, participants were selected according to the following additional criteria: 1) age between 45 and 65 years; 2) blood pressure not exceeding 160/100 mm Hg; 3) absence of liver disease, diabetes mellitus, thyroid disease, and renal disease; 4) first coronary angiography within 2 years before examination for our study; and 5) first consultation of a physician for cardiac symptoms within 5 years before the examination for our study.

Eligible participants were sent a letter asking whether they had a son 15 to 30 years of age and, if so, whether the son was willing to participate in the study. These sons (identified by their fathers) received a separate letter inviting them to have an oral lipid loading test. Participants also received a short questionnaire about smoking habits, alcohol intake, physical activity, and fat intake.

We screened medical files of 629 patients whose coronary angiographic data met the criteria. Of these patients, 19 had died, 46 had diabetes mellitus, 6 had renal disease, 2 had thyroid disease, 183 had either no son or sons outside the required age range, 58 could not be contacted, 17 had no contact with their children, 78 had a cardiac history exceeding 5 years, and 63 could not be invited for other reasons (hospitalization, other serious diseases). Of 157 families (fathers and sons) who met all the criteria, 55 (either father or son) refused to participate in the study (response, 65%), leaving 102 fathers and 139 sons. The latter had oral lipid loading tests. The study protocol was approved by the medical ethics committees of the Zuiderziekenhuis Rotterdam and the University Hospital Rotterdam. Informed consent forms were obtained from all participants in the study.

Baseline Measurements

Fathers were asked to visit the hospital at 9:00 a.m. after fasting for at least 12 hours. Fathers responded to a questionnaire about the number of first-degree relatives who had had myocardial infarctions and about medication use at the time of the examination (medication was taken to the hospital where the examination took place). Systolic blood pressure and diastolic blood pressure were measured using a random zero sphygmomanometer (Hawksley, Lancing, United Kingdom). Fasting serum blood samples were drawn by antecubital venipuncture for measurement of levels of triglycerides, total cholesterol, low-density lipoprotein (LDL) cholesterol, and HDL cholesterol (and its subfractions HDL2 and HDL3). Height and weight were measured without shoes and without heavy clothing.

The sons were invited to come to the hospital, after the same period of fasting, on a separate day to have an oral lipid loading test. For sons, questionnaires were used to obtain data about use of medication, fat intake, alcohol intake, and smoking habits, referring to a 1-month period before the examination for this study. Daily total fat intake was calculated from an 81-item semiquantitative food frequency questionnaire by using a computerized food-composition table [18]. In the sons, blood samples were taken by antecubital venipuncture for measurement of baseline levels of serum triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol (and its subfractions HDL2 and HDL3), apoprotein A-1, apoprotein A-2, apoprotein B, and retinyl palmitate concentrations. This baseline measurement of lipid levels was taken as the starting point (t0) for the oral lipid loading test. In all of the sons, apolipoprotein E was phenotyped.

Oral Lipid Loading Test

Sons of patients and sons of controls came to the hospital at 7:45 a.m. after an overnight fasting of 12 hours. Height and weight were measured first to calculate body surface area. Five minutes after the venipuncture for obtaining baseline lipid levels (at t0), all participants received a liquid lipid load, which consisted of a mixture of dairy cream (40% fat), egg yolk, milk powder, and retinyl palmitate (in aqueous solution) [15]. Participants received the lipid load in a dose based on their individual body surface area (77.5 g fat, 0.5 g cholesterol, and 27 000 IU of retinyl palmitate per square meter of body surface area). The mixture was consumed within 15 minutes.

The participants received an antecubital venous catheter (Venflon Viggo AB, Helsingborg, Sweden), which was kept open during the test period by means of disposable obturators (Venflon). Through this catheter, blood samples were drawn at 2 (t2), 4 (t4), 5 (t5), 6 (t6), 7 (t7), 8 (t8), 10 (t10), and 12 (t12) hours after starting consumption of the oral lipid load. Total cholesterol, triglyceride, and retinyl palmitate concentrations were determined in serum isolated from these samples. During the 12-hour period, other sources of calories were withheld from participants. Because postprandial exercise has been reported to decrease postprandial lipemia [19], participants stayed in the hospital and were asked to refrain from heavy physical activity during the test period.

Laboratory Analyses

Serum total cholesterol levels were measured using an automated enzymatic method (Boehringer Mannheim, Mannheim, Germany) CHOD-PAP reagent kit [20]. Levels of HDL cholesterol and LDL cholesterol were measured by the same method after precipitation. For HDL cholesterol, the phosphotungstate method according to Burstein [21], with a minor modification as described by Grove [22], was used. For LDL cholesterol, precipitation was carried out with polyvinylsulfate (Boehringer Mannheim). Throughout the entire study period, results of total cholesterol and HDL cholesterol determinations were within limits of the quality control program of the World Health Organization Regional Lipid Reference Centre (Prague, Czechoslovakia).

Levels of apoprotein A-1 and B were assayed using an automated immunoturbidimetric method (Kone Diagnostics, Espoo, Finland). Levels of apoprotein A-2 were determined by radial immunodiffusion against specific antiserum (Boehringer Mannheim, Germany) according to Cheung and Albers [23], with slight modifications. All automated analyses were carried out on the Kone Specific Analyzer (Kone Instruments) using frozen ( –20°C) serum samples. High-density lipoprotein2 and HDL3 in serum were assayed as described by Gidez and colleagues [24] with slight modifications. High-density lipoprotein2 and HDL3 were separated using stepwise precipitation of apoprotein B containing lipoproteins with heparin/Mn2+ and HDL2 with dextran sulfate. Apolipoprotein E phenotyping was done by isoelectric focusing of delipidated serum followed by immunoblotting, using apolipoprotein E antiserum as first antibodies [25]. Retinyl palmitate analyses were done as described previously by Groot and colleagues [15].

Statistical Analysis

Means ±SDs were calculated for baseline characteristics of all family members. The total cholesterol/HDL cholesterol and LDL cholesterol/HDL cholesterol ratios were calculated for fathers and sons, and the apoprotein A-1/apoprotein B ratio was calculated for sons. Baseline differences between patients and controls as well as their respective sons were evaluated using the two group t-test or the Mann-Whitney U test when appropriate. Differences in postprandial responses between sons of patients and sons of controls with regard to triglycerides and retinyl palmitate were evaluated with an age-adjusted repeated-measures analysis to determine if group differences at each postprandial measurement time differed significantly from group differences at any other measurement time. Subsequently, linear regression analysis was used to compare mean group postprandial responses. Adjustments were made for age, HDL2 cholesterol, HDL3 cholesterol, apolipoprotein E phenotype, and daily total fat intake. This was done at each postprandial measurement time (t2 to t12) and for areas under the curve for several time (≥ 2 hour) intervals. In the analyses, individual postprandial measurements and areas under the curve were evaluated after subtracting the initial individual values (t0) for triglyceride and retinyl palmitate levels from all respective postprandial measurements, yielding the net postprandial change.


Results
space
up arrowTop
up arrowMethods
dotResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

Two sons of patients did not tolerate the oral lipid because of gastrointestinal problems and were excluded from the study. All other participants tolerated the fat load well and did not have gastrointestinal symptoms or steatorrhea during or after the test. Two (other than already excluded) participants had baseline triglyceride values of 2.52 and 2.45 mmol/L, respectively. The first participant had six measurements of postprandial retinyl palmitate that were more than 3 to 5 standard deviations above the mean, and the latter participant had five measurements of postprandial triglyceride that were more than 3 to 5 standard deviations above the mean. Because of the marked effect of these outliers on the precision of results obtained in the group as a whole, these two participants were excluded from analyses.

Baseline characteristics are given for both groups of fathers and sons in Table 1. No statistically significant differences were noted between patients and controls. Sons of patients were slightly older and had a lower total fat intake. All patients (n = 59) had had coronary angiography for evaluation of symptoms of chest pain. For controls, indications for coronary angiography were symptoms of chest pain (n = 30), evaluation of cardiac valves (n = 7), suspected cardiomyopathy (n = 5), and ventricular septum defect (n = 1). At the time of coronary angiography, 19 (32.2%) patients and 11 (25.6%) controls were treated for hypertension. The average time elapsed between date of the coronary angiography and date of the examination was 13.2 ±0.9 months (mean ±SE) for patients and 13.2 ±1.1 months for controls.


View this table:
[in this window]
[in a new window]
 
Table 1. Baseline Characteristics of Fathers and Sons*

 

Baseline serum measurements after an overnight fast are given for both groups in Table 2. As expected, patients had higher serum levels of total cholesterol, LDL cholesterol, and triglycerides and had higher total cholesterol/HDL cholesterol and of LDL cholesterol/HDL cholesterol ratios than did controls. Levels of HDL cholesterol and its subfractions tended to be slightly lower in patients than in controls (Table 2). Compared with sons of controls, sons of patients had somewhat less favorable lipoprotein and apoprotein profiles (not statistically significant). Sons of patients had significantly decreased levels of HDL3 cholesterol (P = 0.016) and apoprotein A-2 (P = 0.001) when compared with controls. The frequencies of apolipoprotein E phenotypes did not differ between sons of patients and sons of controls. Apoprotein E2 alleles were present in 8 sons of controls and 6 sons of patients, 1 of whom was of the E2/E2 phenotype. This participant was not an outlier with regard either to baseline lipid profile or postprandial data.


View this table:
[in this window]
[in a new window]
 
Table 2. Baseline Serum Measurements in Fathers and Sons*

 

The mean fat load ingested by sons of patients was 399.4 ±3.2 g (mean ±SE) and by sons of controls was 395.1 ±3.8 g. None of the sons in both groups had previous or current diseases or received medication known to have an effect on lipoprotein metabolism.

Figure 1 shows age-adjusted mean postprandial curves for levels of triglyceride, retinyl palmitate, and total cholesterol. Figure 1(left panel) shows mean postprandial triglyceride curves for sons of patients and sons of controls. In both groups, oral lipid loading led to markedly similar increases in triglyceride concentrations, maximum levels appeared between 4 to 6 hours postprandially. After 12 hours, triglyceride concentrations had decreased below initial levels. The age-adjusted repeated-measures analysis showed an interaction effect between group and time (chi-square test = 19.2; P = 0.014), indicating that the two curves were significantly different from each other.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 1. Serum lipid levels in young adult men after an oral fat load. Levels of postprandial serum triglyceride (left), retinyl palmitate (middle), and total cholesterol (right) are mean values adjusted for age. To convert cholesterol levels to mmol/L, multiply by 0.02586. CAD = coronary artery disease; CAD+ and CAD- refer to sons whose fathers do and do not have coronary artery disease, respectively.

 

In Figure 1(middle panel) the mean postprandial retinyl palmitate curves are shown. Retinyl palmitate concentrations increased from virtually zero in both groups to maximum concentrations between 5 and 6 hours postprandially. Thereafter, retinyl palmitate concentrations decreased to levels at t12 that were approximately tenfold the initial levels at t0. The repeated-measures analysis for these curves indicated no significant difference (chi-square test = 6.42; P = 0.60).

In Figure 1(right panel), curves are shown for postprandial total cholesterol responses. Sons of patients had higher mean total cholesterol levels at t0 than did sons of controls, and this difference remained remarkably constant during the lipid loading test, showing no significant response to the intervention. The age-adjusted difference in mean cholesterol levels (mean of all cholesterol measurements) was 2.3 ±5.87 mg/dL (mean ±SE; P = 0.70).

A slight difference in age was noted between sons of patients and sons of controls. Age has been shown to have an effect on postprandial lipoprotein changes [26] and postprandial retinyl ester response [27], and therefore the differences in postprandial response between sons of patients and sons of controls were adjusted for age. Table 3 shows the age-adjusted differences between net postprandial changes in triglyceride and retinyl palmitate responses between sons of patients and sons of controls. Triglyceride response differences showed a maximum at t5 and reached significance at times t8, t10, and t12. With respect to retinyl palmitate, sons of patients and sons of controls showed a slight difference in response, increasing to a maximum at t5 to t6. None of the retinyl palmitate differences was found to be statistically significant.


View this table:
[in this window]
[in a new window]
 
Table 3. Postprandial Triglyceride and Retinyl Palmitate Responses in Sons of Patients with Coronary Artery Disease and Sons of Controls*

 

In Figure 2 A, age-adjusted areas under the curves for 2-hour time intervals are given for postprandial triglyceride responses in sons of patients and sons of controls. Peak areas for both groups were found in the interval t4 to t6. Differences were mainly found in intervals t (6) to t8, t8 to t10, and t10 to t12. In the latter interval, the triglyceride response of sons of controls decreased below t0 (baseline) levels to a greater extent than in sons of patients. Figure 2 Bshows total area under the curves for 10-, 8-, 6-, and 4-hour time intervals up to t12. For all intervals, areas under the curve differed significantly between groups. Figures 2C and 2D show similar data for retinyl palmitate responses in the groups. For 2-hour intervals and larger intervals, areas under the curves for sons of patients tended to be higher, although differences did not reach statistical significance.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 2. Age-adjusted areas under the curve for levels of postprandial triglyceride and retinyl palmitate. A. Areas under the curve for postprandial triglyceride levels for 2-hour time intervals. B. Areas under the curve for larger time intervals. C and D. Areas under the curve for postprandial retinyl palmitate. Closed bars = sons of patients with coronary artery disease; open bars = sons of controls (those without coronary artery disease). * = P < 0.05; {dagger} = P < 0.01.

 
The results for postprandial retinyl palmitate levels as well as triglyceride levels did not materially change after adjustment for baseline HDL2 cholesterol levels, HDL3 cholesterol levels, and apolipoprotein E phenotype. Total fat intake was decreased in sons of patients compared with sons of controls (P = 0.012; (Table 1). Adjustment for this difference in postprandial analyses did not change the results, with adjusted group differences in triglyceride levels at t8 of 0.32 mmol/L [95% CI, 0.04 to 0.59], at t10 of 0.2 mmol/L (CI, 0.047 to 0.36), and at t12 of 0.1 mmol/L (CI, 0.002 to 0.26). All sons were asked whether they had changed their lifestyles with regard to smoking habits, physical activity, and fat intake since their fathers had had cardiac examination. None of the group differences was statistically significant. Also, a similar analysis of sons who reported to live separately from their fathers at the time of examination (45 sons of patients [56%] and 24 sons of controls [42%]) yielded no significant group differences with respect to lifestyle changes. An analysis of postprandial data in these groups showed similar results, with sons of patients having higher triglyceride levels at t8 (difference, 0.47 mmol/L; CI, –0.018 to 0.95) and t10 (difference, 0.29 mmol/L; CI, 0.015 to 0.57). When analyses were done for participants with normal levels of triglycerides only (serum triglyceride ≤ 2.28 mmol/L), thereby excluding 13 participants, no major changes in the results were found.


Discussion
space
up arrowTop
up arrowMethods
up arrowResults
dotDiscussion
down arrowAuthor & Article Info
down arrowReferences

Familial aggregation of risk factors for coronary artery disease is well established, and the offspring of patients with very severe coronary artery disease are at increased risk for this disease [28, 29]. We assessed whether this increased familial risk was related to postprandial metabolic handling of an oral fat load in healthy young male adults whose fathers had severe coronary artery disease. Baseline measurements showed that sons of patients and sons of controls had similar levels of lipids and apolipoproteins, only levels of HDL3 cholesterol and apoprotein A-2 were significantly decreased in sons of patients.

After oral lipid loading, however, prolonged postprandial hypertriglyceridemia was observed in sons of patients, amounting to statistically significant group differences of 0.35 mmol/L after 8 hours, 0.21 mmol/L after 10 hours, and 0.13 mmol/L after 12 hours. Differences in postprandial triglyceride levels between groups were mainly observed in the declining part of the curves, which suggests a delayed clearance of triglyceride from plasma. Data on postprandial retinyl palmitate responses also suggest similar differences for postprandial triglyceride levels with regard to the direction of the difference and the postprandial period in which differences appeared. However, these latter differences were not statistically significant.

A marked contrast between patients with coronary artery disease and controls with regard to angiographic findings was chosen to minimize the chance of misclassification of patients and also because of the anticipated subtle differences between both groups of offspring. Considering the efforts asked on a strictly voluntary basis from fathers, and particularly their offspring, the response rate of 65% in this study is satisfactory. However, it is possible that postprandial lipoprotein metabolism in these young healthy participants was in some way differentially related to the response in both groups and, although unlikely, it is possible that selection mechanisms have affected the findings. Because contraceptive steroids have an effect on postprandial lipid metabolism in young healthy women [30], we restricted the study to sons.

Chylomicron metabolism is thought to occur essentially in two successive steps. First, these particles interact with lipoprotein lipase, an enzyme that is located on capillary endothelial surfaces of various tissues, including heart, skeletal muscle, and adipose tissue [31]. This lipase catalyzes the hydrolysis of triglycerides, and this results in uptake of free fatty acids by tissues [32]. Thereafter, resulting chylomicron remnant particles are taken up relatively quickly and efficiently [33] by parenchymal cells in the liver. The importance of this process, with regard to atherogenesis, is that any hampering in this course of events might lead to higher plasma levels of atherogenic triglyceride-rich lipoproteins and their remnants.

In principle, the oral lipid loading test cannot distinguish between mechanisms involved in chylomicron entry into and clearance of chylomicrons and their remnants from the circulation. In our study, no attempt was made to assess differences between intestinal lipid absorption in the two groups of young adult men. In a study of postprandial lipoprotein metabolism, Weintraub and colleagues [13] showed that gastrointestinal transit time was similar in normal participants and participants with different types of hyperlipoproteinemias. Previous studies [14-16] showed that mean triglyceride and mean retinyl palmitate response curves are similar during the first 4 hours postprandially when comparing patients and controls, which we also found in our study in sons of such patients. This suggests that differences in fat absorption or in intestinal secretion, if any, are not likely to explain group differences during the second half of the test period.

Retinyl palmitate is a useful marker of the metabolism of intestinally derived triglyceride-rich lipoproteins and their remnants because it is incorporated into the core of these lipoproteins [34] and is retained within them until their irreversible clearance from plasma by the liver [35]. Although considerable postprandial exchange between lipoproteins of total retinyl esters has been reported in humans [36], little exchange of retinyl palmitate between intestinally derived lipoproteins and other lipoproteins has been shown [37, 38]. In our study, retinyl palmitate responses showed considerable interindividual variation in both groups, which may explain why differences between group responses did not reach statistical significance. An alternative explanation might be that the postprandial retinyl ester response is greater in older persons than in younger persons [27], thus making it more difficult to detect group differences in the young. Further, postprandial hypertriglyceridemia may partly be induced by endogenous very-low-density lipoprotein and its remnants [39], which do not contain retinyl palmitate. Finally, significant group differences in levels of retinyl palmitate may emerge after the 12-hour measuring period used in the present study and, thus, may have been missed [14].

In our study, data were analyzed after subtracting individual fasting triglyceride levels and retinyl palmitate levels from respective subsequent measurements. Differences in body height and weight were considered by standardizing the oral lipid load to body surface area as a function of body height and weight. Possible confounding effects of age, HDL (2) cholesterol levels, HDL3 cholesterol levels, and apolipoprotein E phenotype were adjusted for in the analysis. Apolipoprotein E polymorphism has recently been shown to have an effect on postprandial retinyl palmitate concentrations [40]. Adjustment for these factors did not materially change results with regard to group differences.

The hypothesis that postprandial lipoprotein metabolism plays an essential role in atherogenesis was first postulated by Zilversmit [3]. This hypothesis was addressed in recent studies in humans [14-16] in which patients with coronary artery disease were compared with controls with respect to postprandial lipemia; the study found that patients had higher postprandial triglyceride and retinyl palmitate responses. In another study, Simons and colleagues [41] found that 4 hours postprandially the apoprotein B48/apoprotein B100 ratio, used as a relative measure of chylomicrons and chylomicron remnants in plasma, was higher in patients with coronary artery disease than in controls. In addition, a positive correlation between the postprandial triglyceride response to an oral lipid load and carotid artery wall thickness has been reported [42]. These studies suggest that prolonged presence of triglyceride-rich lipoproteins in plasma may indeed play a role in atherogenesis.

The design of our investigation enabled us to examine a group of young adult men at high familial risk for developing clinical manifestations of coronary artery disease much later in life. One advantage of the design of this study is that sons of these patients are not exposed to treatments such as medication that could alter triglyceride metabolism, as might occur when patients themselves are studied. However, if patients have been given advice about lifestyle, this may in turn have led to lifestyle changes in their sons. In both groups of sons, most reported not to have changed their levels of physical activity, smoking behavior, and fat intake since their fathers were examined for cardiac symptoms; approximately equal proportions reported to eat less fat. Additionally, an analysis of sons living separately from their fathers, who are assumed to be less influenced by lifestyle advice given to their fathers, yielded similar results with statistically significant differences in the declining part of the triglyceride curves, despite the considerably decreased number of participants. Although no major differences were noted with regard to reported fat intake, daily total fat intake as calculated from the food frequency questionnaire was significantly decreased in sons of patients than in sons of controls. Long- and short-term effects of fat intake on postprandial lipoprotein levels have been reported [43], but in our study, adjustment for daily total fat intake did not change postprandial results. Thus, we believe that changes in physical activity, smoking behavior, and fat intake are not likely to explain postprandial differences found between both groups of sons.

Our data show that healthy young sons whose fathers have established coronary artery disease have prolonged postprandial hypertriglyceridemia. This finding suggests that changes in postprandial lipid metabolism are associated with familial risk for coronary atherosclerosis.


Author and Article Information
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
dotAuthor & Article Info
down arrowReferences

Erasmus University Medical School, Rotterdam. Zuiderziekenhuis, Rotterdam. TNO Institute for Aging and Vascular Research, Gaubius Laboratory, Leiden, the Netherlands.
Requests for Reprints: C.S.P.M. Uiterwaal, MD, Erasmus University Medical School, Department of Epidemiology & Biostatistics, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands.
Acknowledgments: The authors thank Ms. Lorette O.M. Hulsman for assistance with conducting the study, Ms. Jeannette M. Vergeer-Drop for assistance in laboratory analyses, and cardiologists Dr. H.J. Kingma (Antonius Ziekenhuis, Nieuwegein, the Netherlands), Dr. Ph.W. Fels (Refaja Ziekenhuis, Dordrecht, the Netherlands), and Dr. F.J. ten Cate (University Hospital, Rotterdam, the Netherlands) for helping select the patients.
Grant Support: By grant 87058 from the Netherlands Heart Foundation.


References
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowAuthor & Article Info
dotReferences

1. Newman WP 3d, Freeman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med. 1986; 314:138-44.[Abstract]

2. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. JAMA. 1990; 264:3018-24.

3. Zilversmit DB. Atherosclerosis: a postprandial phenomenon. Circulation. 1979; 60:473-85.

4. Goldstein JL, Ho YK, Brown MS, Innerarity TL, Mahley RW. Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine ß-very low density lipoproteins. J Biol Chem. 1980; 255:1839-48.

5. Gianturco SH, Lin AH, Hwang SL, Young J, Brown SA, Via DP, et al. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins. J Clin Invest. 1988; 82:1633-43.

6. Parthasarathy S, Quinn MT, Schwenke DC, Carew TE, Steinberg D. Oxidative modification of ß-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 1989; 9:398-404.

7. Pearson TA, Bulkley BH, Achuff SC, Kwiterovich PO, Gordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol. 1979; 109:285-95.

8. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986; 256:2835-8.

9. Davis CE, Gordon D, LaRosa J, Wood PD, Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations. The Lipid Research Clinics Program Prevalence Study. Circulation. 1980; 62(4 Pt 2):24-30.

10. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis. 1984; 4:225-31.

11. Patsch JR, Prasad S, Gotto AM Jr, Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest. 1987; 80:341-7.

12. Hazzard WR, Bierman EL. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-ß disease (type III hyperlipoproteinemia). Metabolism. 1976; 25:777-801.

13. Weintraub MS, Eisenberg S, Breslow JL. Different patterns of postprandial lipoprotein metabolism in normals, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest. 1987; 79:1110-9.

14. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, et al. Postprandial lipemia, fenofibrate and coronary artery disease. Arteriosclerosis. 1990; 85:193-202.

15. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 1991; 11:653-62.

16. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 1992; 12:1336-45.

17. Slyper AH. A fresh look at the atherogenic remnant hypothesis. Lancet. 1992; 340:289-91.

18. Commissie N.C.V.'s Gravenhage: Voorlichtingsbureau voor de voeding. N.C.V. tabel (Dutch Computerized Food Composition Table); 1989.

19. Schlierf G, Dinsenbacher A, Kather H, Kohlmeier M, Haberbosch W. Mitigation of alimentary lipemia by postprandial exercise-phenomena and mechanisms. Metabolism. 1987; 36:726-30.

20. van Gent CM, van der Voort HA, de Bruyn AM, Klein F. Cholesterol determinations. A comparative study of methods with special reference to enzymatic procedures. Clin Chim Acta. 1977; 75:243-51.

21. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970; 11:583-95.

22. Grove TH. Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. Clin Chim Acta. 1979; 25:560-4.

23. Cheung MC, Albers JJ. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J Clin Invest. 1977; 60:43-50.

24. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high-density lipoproteins by a simple precipitation procedure. J Lipid Res. 1982; 23:1206-23.

25. Havekes LM, de Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res. 1987; 28:455-63.

26. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988; 29:469-79.

27. Krasinski SD, Cohn JS, Schaefer EJ, Russell RM. Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins. J Clin Invest. 1990; 85:883-92.

28. Morrison JA, Kelly K, Horvitz R, Khoury P, Laskarzewski PM, Mellies MJ, et al. Parent-offspring and sibling lipid and lipoprotein associations during and after sharing household environments: the Princeton School District Family Study. Metabolism. 1982; 31:158-66.

29. Weinberg R, Webber LS, Berenson GS. Hereditary and environmental influence on cardiovascular risk factors for children: the Bogalusa Heart Study. Am J Epidemiol. 1982; 116:385-93.

30. Berr F, Eckel RH, Kern F Jr. Contraceptive steroids increase hepatic uptake of chylomicron remnants in health young women. J Lipid Res. 1986; 27:645-51.

31. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978; 298:1265-73.

32. Redgrave TG. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest. 1970; 49:465-71.

33. Stalenhoef AF, Malloy MJ, Kane JP, Havel RJ. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A. 1984; 81:1839-43.

34. Goodman DS, Blomstrand B, Werner B, Huang HS, Shiratori T. The intestinal absorption and metabolism of vitamin A and ß-carotene in man. J Clin Invest. 1966; 45:1615-23.

35. Sherrill BC, Innerarity TL, Mahley RW. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J Biol Chem. 1980; 225:1804-7.

36. Krasinski SD, Cohn JS, Russell RM, Schaefer EJ. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism. 1990; 39:357-65.

37. Wilson DE, Chan IF, Ball M. Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low-density lipoproteins. Metab Clin Exp. 1983; 32:514-7.

38. Berr F, Kern F Jr. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. J Lipid Res. 1984; 25:805-12.

39. Cohn JS, McNamara JR, Krasinski SD, Russell RM, Schaefer EJ. Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration. Metabolism. 1989; 38:484-90.

40. Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet. 1994; 54:341-60.

41. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case–control study. Atherosclerosis. 1987; 65:181-9.

42. Ryu JE, Howard G, Craven TE, Bond MG, Hagaman AP, Crouse JR 3d. Postprandial triglyceridemia and carotid arteriosclerosis in middle-aged subjects. Stroke. 1992; 23:823-8.

43. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest. 1988; 82:1884-93.

Related articles in Annals:

Editorials
Triglyceride Levels in Sons of Patients with Coronary Artery Disease
Scott M. Grundy
Annals 1994 121: 614-615. [Full Text]  



This article has been cited by other articles:


Home page
Diabetes CareHome page
R. S. Rosenson, D. A. Wolff, A. L. Huskin, I. B. Helenowski, and A. W. Rademaker
Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome
Diabetes Care, August 1, 2007; 30(8): 1945 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. M Gatto, D. R Sullivan, and S. Samman
Postprandial effects of dietary trans fatty acids on apolipoprotein(a) and cholesteryl ester transfer
Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1119 - 1124.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sdringola, K. Nakagawa, Y. Nakagawa, S. W. Yusuf, F. Boccalandro, N. Mullani, M. Haynie, M. J. Hess, and K. L. Gould
Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 263 - 272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Marin, J. Lopez-Miranda, P. Gomez, E. Paz, P. Perez-Martinez, F. Fuentes, J. A. Jimenez-Pereperez, J. M. Ordovas, and F. Perez-Jimenez
Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism
Am. J. Clinical Nutrition, August 1, 2002; 76(2): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. M. Yli-Jokipii, U. S. Schwab, R. L. Tahvonen, J.-P. Kurvinen, H. M. Mykkanen, and H. P. T. Kallio
Triacylglycerol Molecular Weight and to a Lesser Extent, Fatty Acid Positional Distribution, Affect Chylomicron Triacylglycerol Composition in Women
J. Nutr., May 1, 2002; 132(5): 924 - 929.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
D. A. Hyson, T. G. Paglieroni, T. Wun, and J. C. Rutledge
Postprandial Lipemia is Associated With Platelet and Monocyte Activation and Increased Monocyte Cytokine Expression in Normolipemic Men
Clinical and Applied Thrombosis/Hemostasis, April 1, 2002; 8(2): 147 - 155.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Lundahl, A. Hamsten, and F. Karpe
Postprandial Plasma ApoB-48 Levels Are Influenced by a Polymorphism in the Promoter of the Microsomal Triglyceride Transfer Protein Gene
Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 289 - 293.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Gaenzer, W. Sturm, G. Neumayr, R. Kirchmair, C. Ebenbichler, A. Ritsch, B. Foger, G. Weiss, and J. R Patsch
Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men
Cardiovasc Res, December 1, 2001; 52(3): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Yli-Jokipii, H. Kallio, U. Schwab, H. Mykkanen, J.-P. Kurvinen, M. J. Savolainen, and R. Tahvonen
Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response
J. Lipid Res., October 1, 2001; 42(10): 1618 - 1625.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Shimono, N. Kuwamura, Y. Nakamura, and H. Koshiyama
Lack of Effect of Pioglitazone on Postprandial Triglyceride Levels in Type 2 Diabetes
Diabetes Care, May 1, 2001; 24(5): 971 - 971.
[Full Text]


Home page
J. Nutr.Home page
R. D. Mattes
Oral Exposure to Butter, but Not Fat Replacers Elevates Postprandial Triacylglycerol Concentration in Humans
J. Nutr., May 1, 2001; 131(5): 1491 - 1496.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
S. C Couch, C. R Isasi, W. Karmally, W. S Blaner, T. J Starc, D. Kaluski, R. J Deckelbaum, H. N Ginsberg, S. Shea, and L. Berglund
Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers Study
Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1119 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. P Bantle, S. K Raatz, W. Thomas, and A. Georgopoulos
Effects of dietary fructose on plasma lipids in healthy subjects
Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1128 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H. Relas, H. Gylling, R. A. Rajaratnam, and T. A. Miettinen
Postprandial Retinyl Palmitate and Squalene Metabolism Is Age Dependent
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2000; 55(11): 515B - 521.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Cohn, C. Marcoux, and J. Davignon
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins
Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2474 - 2486.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Hadjadj, J.-L. Paul, L. Meyer, V. Durlach, B. Vergès, O. Ziegler, P. Drouin, and B. Guerci
Delayed Changes in Postprandial Lipid in Young Normolipidemic Men after a Nocturnal Vitamin A Oral Fat Load Test
J. Nutr., September 1, 1999; 129(9): 1649 - 1655.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Weintraub, I. Grosskopf, Y. Trostanesky, G. Charach, A. Rubinstein, and N. Stern
Thyroxine Replacement Therapy Enhances Clearance of Chylomicron Remnants in Patients with Hypothyroidism
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2532 - 2536.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
L. F. Tinker, E. J Parks, S. R. Behr, B. O. Schneeman, and P. A. Davis
(n-3) Fatty Acid Supplementation in Moderately Hypertriglyceridemic Adults Changes Postprandial Lipid and Apolipoprotein B Responses to a Standardized Test Meal
J. Nutr., June 1, 1999; 129(6): 1126 - 1134.
[Abstract] [Full Text]


Home page
CirculationHome page
D. M. Waterworth, J. Ribalta, V. Nicaud, J. Dallongeville, S. E. Humphries, and P. Talmud
ApoCIII Gene Variants Modulate Postprandial Response to Both Glucose and Fat Tolerance Tests
Circulation, April 13, 1999; 99(14): 1872 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.-L. M. Gronholdt
Ultrasound and Lipoproteins as Predictors of Lipid-Rich, Rupture-Prone Plaques in the Carotid Artery
Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 2 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Lemieux, R. Fontani, K. D. Uffelman, G. F. Lewis, and G. Steiner
Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins
J. Lipid Res., October 1, 1998; 39(10): 1964 - 1971.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
J. R. McNamara, P. K. Shah, K. Nakajima, L. A. Cupples, P. W. F. Wilson, J. M. Ordovas, and E. J. Schaefer
Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
Clin. Chem., June 1, 1998; 44(6): 1224 - 1232.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.